Candida Support
Dr. Tobias
Overview
Candida Support combines several ingredients that are traditionally used to support gut health, immune function, and reduce unpleasant effects from die-off. While some individual ingredients have shown promise in clinical studies, more research is needed to determine the effectiveness of this specific formulation.
The Good
Contains oregano leaf extract, which has shown antimicrobial properties.
Includes caprylic acid, known to increase ketone levels and support lipid metabolism.
Provides L. Acidophilus, a probiotic beneficial for gut health.
The Bad
Potential for allergic reactions due to black walnut.
Gastrointestinal discomfort possible, especially at higher doses.
Limited high-quality human studies for many ingredients.
Is it for you?
Best For: Individuals seeking to support gut health, maintain healthy yeast balance, or address mild digestive imbalances.
Skip If: Pregnant, nursing, on medication, or have a medical condition without consulting a doctor. If allergic to any ingredients.
Ingredients Analysis
Oregano Leaf Extract
500 mgCaprylic Acid
400 mgL. Acidophilus
100 mgProtease
50 mgCellulase
32 mgArabinogalactan
50 mgAnise Seed Extract
50 mgWormwood Leaf Powder
50 mgHow to Use
Typically, take 1-2 capsules twice daily with meals, or as directed by a healthcare professional.
Daily
Morning & Evening
With food
Who Should Use This
Best For:
Similar Products
Recommended Articles
Rhodiola Supplements: Effective Ingredients & Levels
Rhodiola rosea supplements should be standardized to 3% rosavins for stress management efficacy.
Melatonin & Chronic Insomnia: Effectiveness & Dosage
Melatonin is generally effective for chronic insomnia, with minimal side effects and varied dosages.
Berberine vs Metformin: Weight Loss Showdown 2025
Berberine and metformin both show promising weight loss effects by activating AMPK, with berberine possibly having a slight edge in certain populations.
CBD for Chronic Pain: 2025 Clinical Trial Insights
CBD shows promising results in chronic pain management, with clinical trials up to 2025 highlighting its safety and efficacy.